Is autologous dendritic cell therapy available in China for pancreatic cancer?

Yes. It is available through the Boao Lecheng transformation/application framework under a “pilot first” policy, at Boao Super Hospital, subject to medical assessment.

How much does autologous DC therapy cost in China?

The estimated cost is ¥388,000, or approximately US$57,700, per session. Patients should confirm the final price and what it includes with the hospital.

Who may qualify for autologous dendritic cell therapy?

Patients with pancreatic cancer, colorectal cancer, and other immune-related solid tumors may be considered. Assessment takes into account pathological type, stage, previous treatments, and overall condition.

Can international patients explore this treatment in China?

Yes, international patients can explore the pathway through medical consultation and eligibility assessment. Final eligibility is determined by the treating medical team.

top of page

ChinaCurelink
a MedeboundHEALTH Company

FREE CONSULTATION

Autologous Dendritic Cell (DC) Immunotherapy for Pancreatic and Colorectal Cancer in China: 2026 International Patient Guide

ChinaCureLink

Thu Aug 27 2026

6 min read

Widget Didn’t Load

Check your internet and refresh this page.

If that doesn’t work, contact us.

bottom of page